Q1 FY2027 · ended Jul 31, 2026 · Revenue $9.76B, +13.7% YoY · Filed Sep 3, 2026
Medtronic plc (MDT) files with the SEC under industry code 3845, Electromedical & Electrotherapeutic Apparatus. In Q1 of fiscal 2027, the quarter ended Jul 31, 2026, it reported revenue of $9.8 billion and net income of $1.5 billion. Free cash flow was $1.3 billion. As of Jul 31, 2026 it held $8.8 billion in cash and investments and $25.6 billion in total debt.
Revenue
$9.76B
+13.7% vs year-ago quarter
Net income
$1.47B
+41.3% vs year-ago quarter
Operating cash flow
$1.79B
+64.8% vs year-ago quarter
Free cash flow
$1.29B
+120.9% vs year-ago quarter
EPS
$1.14
+40.7% vs year-ago quarter
Dividend per share
$0.72
+1.4% vs year-ago quarter
Shares outstanding
1.28B
-0.3% vs year-ago quarter
Net cash
$-16.80B
Q1 FY2027
Operating margin
18.1%
TTM
Company profile
- Industry
- Electromedical & Electrotherapeutic Apparatus (SIC 3845)
- Listed as
- MDT (NYSE)
- Fiscal year ends
- April 24
- Headquarters
- Galway
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1613103
- Former names
- Medtronic Ltd (until Jan 15, 2015); Medtronic Holdings Ltd (until Nov 21, 2014)
Other Electromedical & Electrotherapeutic Apparatus companies
- LivaNova PLC LIVN
- Integer Holdings Corp ITGR
- Axogen, Inc. AXGN
- TransMedics Group, Inc. TMDX
- CONMED Corp CNMD
- Ceribell, Inc. CBLL
- InMode Ltd. INMD
- CapsoVision, Inc CV
All 31 Electromedical & Electrotherapeutic Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q1 FY2027 Jul 31, 2026 |
Q4 FY2026 Apr 24, 2026 |
Q3 FY2026 Jan 23, 2026 |
Q2 FY2026 Oct 24, 2025 |
Q1 FY2026 Jul 25, 2025 |
|---|---|---|---|---|---|
| Revenue | $9.8B | $9.8B | $9.0B | $9.0B | $8.6B |
| Operating income | $1.8B | $1.9B | $1.5B | $1.7B | $1.4B |
| Net income | $1.5B | $1.2B | $1.1B | $1.4B | $1.0B |
| Diluted EPS | $1.14 | $0.97 | $0.89 | $1.07 | $0.81 |
| Operating cash flow | $1.8B | $2.6B | $2.7B | $925.0M | $1.1B |
| Free cash flow | $1.3B | $2.1B | $2.3B | $457.0M | $584.0M |
| Total assets | $93.3B | $93.0B | $91.5B | $91.3B | $91.0B |
| Total liabilities | $42.5B | $43.0B | $42.3B | $42.5B | $42.8B |
| Stockholders' equity | $50.2B | $49.5B | $49.0B | $48.7B | $47.9B |
| Cash and investments | $8.8B | $9.2B | $8.4B | $8.3B | $8.1B |
| Total debt | $25.6B | $27.4B | $27.9B | $27.7B | $26.2B |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Officer or director change, Shareholder vote results, Regulation FD disclosure
|
Oct 19, 2026 | Oct 15, 2026 |
| 8-K |
Current report
Other events
|
Sep 17, 2026 | Sep 17, 2026 |
| 10-Q | Quarterly report | Sep 3, 2026 | Jul 31, 2026 |
| 8-K |
Current report
Results of operations
|
Sep 1, 2026 | Sep 1, 2026 |
| ARS | Annual report to shareholders | Aug 24, 2026 | Apr 24, 2026 |
| 10-K | Annual report | Jun 18, 2026 | Apr 24, 2026 |
All 1001 Medtronic plc SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.